---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-004168"
form_type: "8-K"
ticker: "CGON"
cik: "0001991792"
company_name: "CG Oncology, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:46:30.986619+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CG Oncology enters amended employment agreements with CEO, President, and three other executives with enhanced severance

## Summary
- CEO Arthur Kuan and President/COO Ambaw Bellete: 1.5x salary + prorated bonus outside CIC; 2.0x salary + full bonus inside CIC.
- COBRA premium payments for up to 18 months (CIC: 24 months) and 18-month equity acceleration (CIC: full vesting).
- Bellete's June 2023 option of 432,311 shares gets full accelerated vesting after second anniversary on termination without cause outside CIC.
- CMO Kasturi, CFO Roche, GC Patterson: 1.0x salary + 12-month COBRA outside CIC; 1.5x salary + 18-month COBRA inside CIC.
- All agreements dated January 9, 2025; full text to be filed in 2024 Form 10-K.

## SEC filing metadata
- accession: 0000950170-25-004168
- form_type: 8-K
- ticker: CGON
- cik: 0001991792
- company_name: CG Oncology, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1991792/000095017025004168/0000950170-25-004168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1991792/000095017025004168/ck0001991792-20250109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-004168
- JSON: https://secwatch.observer/filing/0000950170-25-004168.json
- Plain text: https://secwatch.observer/filing/0000950170-25-004168.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.